Angiodynamics, Inc. (ANGO) Beats Q4 EPS View by 1c; Guides Fy13
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.62 -0.32%
Revenue Growth %: +6.3%
Financial Fact:
Operating income: 3.57M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +6.3%
Financial Fact:
Operating income: 3.57M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Angiodynamics, Inc. (NASDAQ: ANGO) reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $57.7 million versus the consensus estimate of $52.97 million.
Sees FY2013 EPS of $0.49-$0.51, versus the consensus of $0.48. Angiodynamics, Inc. sees FY2013 revenue of $360-$363 million, versus the consensus of $356.7 million.
For earnings history and earnings-related data on Angiodynamics, Inc. (ANGO) click here.
Sees FY2013 EPS of $0.49-$0.51, versus the consensus of $0.48. Angiodynamics, Inc. sees FY2013 revenue of $360-$363 million, versus the consensus of $356.7 million.
For earnings history and earnings-related data on Angiodynamics, Inc. (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- TD Cowen on Alaska Air (ALK): 'Can Alaska ReAccelerate?'
- Top Wealth Group expects net profit to double in fiscal 2026
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
